Methyl 3-(4-aminopiperidin-1-yl)propanoate dihydrochloride

Catalog No.: 
ACJEUE787
CAS No.: 
294180-07-7
Molecular Formula: 
C9H20Cl2N2O2
Molecular Weight: 
259.18
Methyl 3-(4-aminopiperidin-1-yl)propanoate dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$225.00InquiryInquiry
100mg95%$327.00InquiryInquiry
250mg95%$457.00InquiryInquiry
1g95%$907.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(4-aminopiperidin-1-yl)propanoate dihydrochloride
IUPAC Namemethyl 3-(4-aminopiperidin-1-yl)propanoate dihydrochloride
MDL No.MFCD15200858
Molecular FormulaC9H20Cl2N2O2
Molecular Weight259.18
SMILESO=C(OC)CCN1CCC(N)CC1.[H]Cl.[H]Cl
InChI KeyWOQSMSMXSRFZEX-UHFFFAOYSA-N
Synonymmethyl 3-(4-aminopiperidin-1-yl)propanoate dihydrochloride
CAS No.294180-07-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJEUE787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACJEUE787 route product structure diagram
    ACJEUE787294180-07-7
Inquiry

2. ACJEUE787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJEUE787 route product structure diagram
    ACJEUE787294180-07-7
Inquiry

3. ACJEUE787 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJEUE787 route product structure diagram
    ACJEUE787294180-07-7
Inquiry

Comments (0)